Atlas Trials

Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects

Clinical trial NCT00166322 · COMPLETED

Trial details

NCT number
NCT00166322
Sponsor
Ludwig-Maximilians - University of Munich
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2004-01-01
Primary completion
2007-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.